Literature DB >> 16567864

Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak.

Anita Chakravarti1, Rajni Kumaria.   

Abstract

BACKGROUND &
OBJECTIVE: Dengue haemorrhagic fever (DHF) is a severe illness caused by dengue viruses, the pathogenesis of which is not fully understood. Immune enhancement caused by cytokines, interferon and activated complement system is one of the hypotheses proposed to explain the haemorrhagic form of disease. This study was undertaken to investigate the role of pro-inflammatory cytokines tumour necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) in dengue infection, and their possible association with disease severity.
METHODS: Blood samples were collected from 60 patients; 28 patients of DF and 32 of DHF (clinically categorized into DF or DHF as per WHO criteria) from September to November 2003 at Delhi. Fifteen healthy individuals were included as control. All the patients were confirmed positive for dengue infection by serology or by reverse transcriptase-polymerase chain reaction (RT-PCR). Serum levels of TNF-alpha and IFN-gamma were determined by ELISA.
RESULTS: The levels of both the cytokines were significantly elevated in the disease group as compared to the control group. Significantly higher levels of TNF-alpha; 258.02 pg/ml (P<0.005) were seen in patients having secondary infection, while patients with primary infection had higher level of IFN-gamma; 29.47 pg/ml (P<0.005). TNF-alpha was elevated in the later phase of illness, while IFN-gamma was elevated in early phase also. INTERPRETATION &amp;
CONCLUSION: Overproduction of TNF-alpha during secondary infection may have a role in immunopathogenesis of DHF, however, study of other cytokines produced along with IFN-gamma;, during the course of dengue infection is required to know the specific role of IFN-gamma in DI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567864

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  39 in total

1.  Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability.

Authors:  James F Kelley; Pakieli H Kaufusi; Vivek R Nerurkar
Journal:  Virology       Date:  2011-11-29       Impact factor: 3.616

2.  Harmonic Alignment.

Authors:  Jay S Stanley; Scott Gigante; Guy Wolf; Smita Krishnaswamy
Journal:  Proc SIAM Int Conf Data Min       Date:  2020

3.  Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice.

Authors:  Ricky Cheung; Fran Shen; Joseph H Phillips; Mandy J McGeachy; Daniel J Cua; Paul G Heyworth; Robert H Pierce
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 4.  Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis.

Authors:  Karen Clyde; Jennifer L Kyle; Eva Harris
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

5.  Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype.

Authors:  Ruklanthi de Alwis; Derek J Bangs; Michael A Angelo; Cristhiam Cerpas; Anira Fernando; John Sidney; Bjoern Peters; Lionel Gresh; Angel Balmaseda; Aruna D de Silva; Eva Harris; Alessandro Sette; Daniela Weiskopf
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 6.  Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis.

Authors:  Ashley L St John; Soman N Abraham; Duane J Gubler
Journal:  Nat Rev Microbiol       Date:  2013-05-08       Impact factor: 60.633

7.  The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability.

Authors:  Henry Puerta-Guardo; Arturo Raya-Sandino; Lorenza González-Mariscal; Victor H Rosales; José Ayala-Dávila; Bibiana Chávez-Mungía; Daniel Martínez-Fong; Fernando Medina; Juan E Ludert; Rosa María del Angel
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

8.  An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.

Authors:  Aaron F Carlin; Emily M Plummer; Edward A Vizcarra; Nicholas Sheets; Yunichel Joo; William Tang; Jeremy Day; Jay Greenbaum; Christopher K Glass; Michael S Diamond; Sujan Shresta
Journal:  Cell Rep       Date:  2017-11-07       Impact factor: 9.423

Review 9.  The relationship of interacting immunological components in dengue pathogenesis.

Authors:  David G Nielsen
Journal:  Virol J       Date:  2009-11-27       Impact factor: 4.099

10.  Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study.

Authors:  D Priyadarshini; Rajesh R Gadia; Anuradha Tripathy; K R Gurukumar; Asha Bhagat; Sampada Patwardhan; Nitin Mokashi; Dhananjay Vaidya; Paresh S Shah; D Cecilia
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.